UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.82B |
| 2 |
Linde
LIN
|
+$786M |
| 3 |
Energy Transfer Partners
ET
|
+$666M |
| 4 |
VanEck Gold Miners ETF
GDX
|
+$445M |
| 5 |
UBS Group
UBS
|
+$416M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ETP
Energy Transfer Partners, L.P.
ETP
|
+$1.06B |
| 2 |
Colgate-Palmolive
CL
|
+$665M |
| 3 |
PX
Praxair Inc
PX
|
+$528M |
| 4 |
Apple
AAPL
|
+$503M |
| 5 |
Amazon
AMZN
|
+$468M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.03% |
| 2 | Financials | 6.64% |
| 3 | Healthcare | 6.26% |
| 4 | Consumer Discretionary | 5.11% |
| 5 | Industrials | 4.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2001
State Street Global Allocation ETF
GAL
$312M
| $5.91M | ﹤0.01% |
171,258
+23,528
| +16% | +$856K |
|
2002
MKS Inc
MKSI
$21.7B
| $5.9M | ﹤0.01% |
91,365
-44,021
| -33% | -$3.18M |
|
2003
ProShares Short VIX Short-Term Futures ETF
SVXY
$202M
| $5.89M | ﹤0.01% |
278,724
-196,780
| -41% | -$4.83M |
|
2004
PUT
Estee Lauder
EL
$31.5B
| $5.89M | ﹤0.01% |
+45,300
| New | +$6.15M |
|
2005
Oxford Square Capital
OXSQ
$158M
| $5.88M | ﹤0.01% |
908,490
+141,202
| +18% | +$930K |
|
|
GBT
2006
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $5.87M | ﹤0.01% |
142,880
+65,783
| +85% | +$2.46M |
|
2007
WisdomTree Japan SmallCap Dividend Fund
DFJ
$390M
| $5.86M | ﹤0.01% |
90,997
-4,791
| -5% | -$336K |
|
|
OMP
2008
DELISTED
Oasis Midstream Partners LP Common Units Representing Limited Partner Interests
OMP
| $5.85M | ﹤0.01% |
365,576
+241,869
| +196% | +$4.95M |
|
|
ENDP
2009
PUT
DELISTED
Endo International plc
ENDP
| $5.84M | ﹤0.01% |
800,000
-4,688,200
| -85% | -$64.3M |
|
2010
Barclays
BCS
$94.5B
| $5.84M | ﹤0.01% |
810,047
+264,818
| +49% | +$2.13M |
|
2011
Medifast
MED
$145M
| $5.84M | ﹤0.01% |
46,694
+42,344
| +973% | +$7.24M |
|
|
XRLV
2012
DELISTED
Invesco S&P 500 ex-Rate Sensitive Low Volatility ETF
XRLV
| $5.84M | ﹤0.01% |
180,652
+2,023
| +1% | +$69.3K |
|
2013
Atmos Energy
ATO
$28.8B
| $5.83M | ﹤0.01% |
62,905
-32,852
| -34% | -$3.14M |
|
2014
AMN Healthcare
AMN
$1.29B
| $5.82M | ﹤0.01% |
102,691
+15,010
| +17% | +$842K |
|
2015
TriplePoint Venture Growth BDC
TPVG
$193M
| $5.81M | ﹤0.01% |
533,340
+211,115
| +66% | +$2.59M |
|
2016
CALL
Akamai
AKAM
$17.9B
| $5.8M | ﹤0.01% |
95,000
| – | – |
|
|
JTA
2017
DELISTED
Nuveen Tax-Advantaged Total Return Strategy Fund
JTA
| $5.79M | ﹤0.01% |
570,741
-307,505
| -35% | -$3.59M |
|
|
TMHC
2018
DELISTED
Taylor Morrison
TMHC
| $5.79M | ﹤0.01% |
364,295
+321,088
| +743% | +$5.24M |
|
2019
PUT
Autodesk
ADSK
$50.1B
| $5.79M | ﹤0.01% |
44,982
+36,882
| +455% | +$4.98M |
|
2020
SiriusXM
SIRI
$10.4B
| $5.78M | ﹤0.01% |
101,260
-94,450
| -48% | -$5.74M |
|
|
GHDX
2021
DELISTED
Genomic Health, Inc.
GHDX
| $5.78M | ﹤0.01% |
89,718
+62,572
| +231% | +$4.39M |
|
2022
Chemed
CHE
$7.05B
| $5.77M | ﹤0.01% |
20,382
-462
| -2% | -$139K |
|
2023
Invesco Dorsey Wright Technology Momentum ETF
PTF
$656M
| $5.77M | ﹤0.01% |
328,521
+58,227
| +22% | +$1.08M |
|
|
SPLK
2024
PUT
DELISTED
Splunk Inc
SPLK
| $5.77M | ﹤0.01% |
55,000
| – | – |
|
|
AMID
2025
DELISTED
American Midstream Partners, LP
AMID
| $5.76M | ﹤0.01% |
1,900,399
+1,196,780
| +170% | +$6.52M |
|
Similar funds
UBS Group's Q4 2018 Portfolio in Review
As of Q4 2018, UBS Group held 8,767 positions worth $221B, down 13% from $252B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group's Q4 2018 filing shows 731 new, 3,710 increased, 3,260 reduced and 648 closed positions. Its largest new stake was Linde: 4,971,408 shares worth $776M. The largest sale was Energy Transfer Partners, L.P., an estimated $1.06B.
By sector, the portfolio is most concentrated in Technology at 8% of assets, down from 9.3% a quarter earlier, followed by Financials and Healthcare.
- UBS Group's largest Q4 2018 buy was Linde: 4,971,408 shares worth $776M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2018, an estimated $1.82B increase.
- UBS Group's biggest Q4 2018 reduction was Colgate-Palmolive, cutting an estimated $665M.
- UBS Group fully exited Energy Transfer Partners, L.P. in Q4 2018, selling an estimated $1.06B.
- UBS Group's ten largest holdings make up 15% of its $221B portfolio in Q4 2018.
- UBS Group opened 731 new positions and closed 648 in Q4 2018.
- UBS Group's portfolio value fell 13% quarter-over-quarter to $221B.
Based on UBS Group's 13F filing for Q4 2018, filed 14 Feb 2019.